BeiGene Files Definitive Proxy Statement
Ticker: BEIGF · Form: DEF 14A · Filed: Apr 7, 2025 · CIK: 1651308
| Field | Detail |
|---|---|
| Company | Beigene, LTD. (BEIGF) |
| Form Type | DEF 14A |
| Filed Date | Apr 7, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, annual-meeting, governance
TL;DR
BeiGene filed its proxy statement for the May 21st meeting - shareholders vote soon!
AI Summary
BeiGene, Ltd. filed its definitive proxy statement on April 7, 2025, for its annual meeting on May 21, 2025. The filing, designated as DEF 14A, outlines the company's governance and shareholder matters. Key details regarding the meeting agenda and voting procedures are expected to be detailed within the full proxy materials.
Why It Matters
This filing is crucial for shareholders as it details the agenda for the upcoming annual meeting, including any proposals to be voted on, and provides information on executive compensation and board nominations.
Risk Assessment
Risk Level: low — This is a routine regulatory filing for an annual shareholder meeting and does not contain new material financial or operational information.
Key Numbers
- DEF 14A — Filing Type (Definitive Proxy Statement)
Key Players & Entities
- BeiGene, Ltd. (company) — Registrant
- 0001104659-25-032346 (filing_id) — Accession Number
- 20250407 (date) — Filing Date
- 20250521 (date) — Meeting Date
FAQ
What is the purpose of a DEF 14A filing?
A DEF 14A filing, or Definitive Proxy Statement, is used by companies to solicit proxies from shareholders for an upcoming shareholder meeting, providing details on matters to be voted upon.
When is BeiGene, Ltd.'s annual meeting scheduled?
BeiGene, Ltd.'s annual meeting is scheduled for May 21, 2025.
What is the filing date of this proxy statement?
This definitive proxy statement was filed on April 7, 2025.
Who is the filer of this document?
The filer of this document is BeiGene, Ltd.
What is the SIC code for BeiGene, Ltd.?
The Standard Industrial Classification (SIC) code for BeiGene, Ltd. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 7, 2025 regarding BeiGene, Ltd. (BEIGF).